Gilead Sciences (GILD) Prices $2B Notes Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Gilead Sciences (GILD) shares oversold argues BofA
September 8, 2023 8:54 AM EDTBofA analyst Geoff Meacham upgraded shares of Gilead Sciences (NASDAQ: GILD) to Buy from Neutral, with a price target of $95, up from $88 per share, in a note to clients on Friday.
The analyst told investors that the pharmaceutical company's HIV drug upside remains... More
